AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.53 Cr | ₹-2.95 Cr | ₹9.09 Cr | ₹-19 Cr | ₹-5.84 Cr |
What is the latest Cash Flow from Financing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.53 Cr |
| Mar2024 | ₹-2.95 Cr |
| Mar2023 | ₹9.09 Cr |
| Mar2022 | ₹-19 Cr |
| Mar2021 | ₹-5.84 Cr |
How is Cash Flow from Financing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.53 Cr | Negative | |
| Mar2024 | ₹-2.95 Cr | Negative | |
| Mar2023 | ₹9.09 Cr | Positive | |
| Mar2022 | ₹-19 Cr | Negative | |
| Mar2021 | ₹-5.84 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹191.1 Cr | -6.2% | -10% | -36.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -6.2% |
-10% |
-36.6% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses